GlassScriptPhysician profile
Gregory S Heumann
NPI 1770588568
$1,440.11
in general payments reported to CMS, 2019-2025
9 companies · $63.77 in 2025
The $63.77 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $57.48 · 2021: $20.11 · 2022: $54.26 · 2023: $32.01 · 2024: $53.28 · 2025: $63.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,072.59 | 2019-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $185.73 | 2019-2020 | |
| Abbott Laboratories | $52.41 | 2019-2025 | Diamondback Coronary, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $39.52 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.61 | 2020-2022 | |
| Novo Nordisk INC | $27.71 | 2019 | |
| Pfizer INC. | $18.65 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Heumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.